article · Neurology
This systematic review aims to evaluate the efficacy and safety of plerixafor in patients with high-grade glioma, focusing on its effects on overall survival, progression-free survival, and treatment-related adverse events.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.1212/wnl.0000000000217169
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.